{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:07:54Z","timestamp":1784243274862,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["K Supplement"],"award-info":[{"award-number":["K Supplement"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23AR073334"],"award-info":[{"award-number":["K23AR073334"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R03AR078938"],"award-info":[{"award-number":["R03AR078938"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1136\/ard-2022-223439","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T18:20:11Z","timestamp":1669659611000},"page":"565-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases"],"prefix":"10.1016","volume":"82","author":[{"given":"Naomi J","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2423-5982","authenticated-orcid":false,"given":"Yumeko","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buuthien","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi","family":"Srivatsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily P","family":"Banasiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Bade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7638-0888","authenticated-orcid":false,"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-4618","authenticated-orcid":false,"given":"Jeffrey A","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4708-7038","authenticated-orcid":false,"given":"Zachary S.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2022-223439_bib1","doi-asserted-by":"crossref","first-page":"e002587","DOI":"10.1136\/rmdopen-2022-002587","article-title":"Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 global rheumatology alliance vaccine survey","volume":"8","author":"DiIorio","year":"2022","journal-title":"RMD Open"},{"key":"10.1136\/ard-2022-223439_bib2","doi-asserted-by":"crossref","first-page":"152025","DOI":"10.1016\/j.semarthrit.2022.152025","article-title":"DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: a prospective study","volume":"55","author":"Di Iorio","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2022-223439_bib3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cmi.2021.06.036","article-title":"BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel","volume":"27","author":"Brosh-Nissimov","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1136\/ard-2022-223439_bib4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1080\/13696998.2021.2002063","article-title":"Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2","volume":"24","author":"Di Fusco","year":"2021","journal-title":"J Med Econ"},{"key":"10.1136\/ard-2022-223439_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/annrheumdis-2021-221326","article-title":"Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases","volume":"81","author":"Cook","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223439_bib6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/annrheumdis-2020-217888","article-title":"Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \u2018hot spot\u2019","volume":"79","author":"D'Silva","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223439_bib7","doi-asserted-by":"crossref","first-page":"660-666","DOI":"10.1136\/annrheumdis-2020-219279","article-title":"Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic","volume":"80","author":"Serling-Boyd","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223439_bib8","author":"Organization WH","year":"2021","journal-title":"A clinical case definition of post COVID-19 condition by a Delphi consensus"},{"key":"10.1136\/ard-2022-223439_bib9","author":"Prevention CfDCa"},{"key":"10.1136\/ard-2022-223439_bib10","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.3390\/ijerph18052621","article-title":"Defining Post-COVID symptoms (post-acute COVID, long COVID, persistent Post-COVID): an integrative classification","volume":"18","author":"Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1136\/ard-2022-223439_bib11","doi-asserted-by":"crossref","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1136\/ard-2022-223439_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-Acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"key":"10.1136\/ard-2022-223439_bib13","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/s41467-022-29521-z","article-title":"Persistent COVID-19 symptoms in a community study of 606,434 people in England","volume":"13","author":"Whitaker","year":"2022","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2022-223439_bib14","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/jama.2022.18931","article-title":"Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021","volume":"328","author":"Global Burden of Disease Long COVID Collaborators","year":"2022","journal-title":"JAMA"},{"key":"10.1136\/ard-2022-223439_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","article-title":"Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study","volume":"400","author":"Ballering","year":"2022","journal-title":"Lancet"},{"key":"10.1136\/ard-2022-223439_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2115463","article-title":"Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines in U.S. veterans","volume":"386","author":"Dickerman","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2022-223439_bib17","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.15585\/mmwr.mm7049a2","article-title":"Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021","volume":"70","author":"Bajema","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1136\/ard-2022-223439_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","article-title":"Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study APP: a prospective, community-based, nested, case-control study","volume":"22","author":"Antonelli","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1136\/ard-2022-223439_bib19","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat Med"},{"key":"10.1136\/ard-2022-223439_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jamainternmed.2021.7024","article-title":"Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US","volume":"182","author":"Sun","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1136\/ard-2022-223439_bib21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/annrheumdis-2021-221244","article-title":"Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases","volume":"80","author":"Friedman","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223439_bib22","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/annrheumdis-2021-220597","article-title":"Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease","volume":"80","author":"Haberman","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223439_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.41914","article-title":"Humoral and cellular immune responses to SARS-CoV-2 infection and vaccination in autoimmune disease patients with B cell depletion","volume":"74","author":"Simon","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2022-223439_bib24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","volume":"80","author":"Furer","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-223439_bib25","doi-asserted-by":"crossref","first-page":"1572-1585","DOI":"10.7326\/M21-1757","article-title":"Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study","volume":"174","author":"Deepak","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard-2022-223439_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The short-form McGill pain questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"10.1136\/ard-2022-223439_bib28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jpainsymman.2007.11.013","article-title":"Identifying clinically meaningful fatigue with the fatigue symptom inventory","volume":"36","author":"Donovan","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1136\/ard-2022-223439_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1008842517972","article-title":"Measurement of fatigue in cancer patients: development and validation of the fatigue symptom inventory","volume":"7","author":"Hann","year":"1998","journal-title":"Qual Life Res"},{"key":"10.1136\/ard-2022-223439_bib30","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/rheumatology\/kei181","article-title":"Comparison of the health assessment questionnaire (HAQ) and the modified HAQ (MHAQ) in patients with rheumatoid arthritis","volume":"45","author":"Uhlig","year":"2006","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-223439_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/oxfordjournals.pubmed.a024606","article-title":"A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies?","volume":"19","author":"Jenkinson","year":"1997","journal-title":"J Public Health Med"},{"key":"10.1136\/ard-2022-223439_bib32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/M20-4044","article-title":"How to quantify and interpret treatment effects in comparative clinical studies of COVID-19","volume":"173","author":"McCaw","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard-2022-223439_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2288-13-152","article-title":"Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1136\/ard-2022-223439_bib34","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/jamacardio.2017.2922","article-title":"Restricted mean survival time as a measure to interpret clinical trial results","volume":"2","author":"Kim","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1136\/ard-2022-223439_bib35","article-title":"Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021","author":"Kuodi","year":"2022","journal-title":"medRxiv"},{"key":"10.1136\/ard-2022-223439_bib36","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1056\/NEJMp2119682","article-title":"Challenges in inferring intrinsic severity of the SARS-CoV-2 omicron variant","volume":"386","author":"Bhattacharyya","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2022-223439_bib37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study","volume":"399","author":"Wolter","year":"2022","journal-title":"Lancet"},{"key":"10.1136\/ard-2022-223439_bib38","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41591-022-01887-z","article-title":"Clinical outcomes associated with SARS-CoV-2 omicron (B.1.1.529) variant and BA.1\/BA.1.1 or BA.2 subvariant infection in southern California","volume":"28","author":"Lewnard","year":"2022","journal-title":"Nat Med"},{"key":"10.1136\/ard-2022-223439_bib39","unstructured":"Severity of disease associated with omicron variant as compared with delta variant in hospitalized patients with suspected or confirmed SARS-CoV-2 infection 2022."},{"key":"10.1136\/ard-2022-223439_bib40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5271\/sjweh.3960","article-title":"Return-To-Work, disabilities and occupational health in the age of COVID-19","volume":"47","author":"Godeau","year":"2021","journal-title":"Scand J Work Environ Health"},{"key":"10.1136\/ard-2022-223439_bib41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","article-title":"Attributes and predictors of long COVID","volume":"27","author":"Sudre","year":"2021","journal-title":"Nat Med"},{"key":"10.1136\/ard-2022-223439_bib42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jinf.2022.02.003","article-title":"Determinants of persistence of symptoms and impact on physical and mental wellbeing in long COVID: a prospective cohort study","volume":"84","author":"Righi","year":"2022","journal-title":"J Infect"},{"key":"10.1136\/ard-2022-223439_bib43","doi-asserted-by":"crossref","first-page":"rkac008","DOI":"10.1093\/rap\/rkac008","article-title":"Persistent post-discharge symptoms after COVID-19 in rheumatic and musculoskeletal diseases","volume":"6","author":"Leon","year":"2022","journal-title":"Rheumatol Adv Pract"},{"key":"10.1136\/ard-2022-223439_bib44","article-title":"Risk Factors for \u201cLong Haul\u201d COVID-19 in Rheumatology Outpatients in New York City [abstract]","volume":"73","author":"Barbhaiya","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2022-223439_bib45","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/infdis\/jiab490","article-title":"Markers of immune activation and inflammation in individuals with Postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection","volume":"224","author":"Peluso","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1136\/ard-2022-223439_bib46","article-title":"Neuro-COVID long-haulers exhibit broad dysfunction in T cell memory generation and responses to vaccination","author":"Visvabharathy","year":"2021","journal-title":"medRxiv"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724004436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724004436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2022-223439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:20:49Z","timestamp":1749806449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724004436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0003496724004436"],"URL":"https:\/\/doi.org\/10.1136\/ard-2022-223439","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2022-223439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 \u00a9 Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}